CD163 is a tumor-associated macrophage marker, the high level of Monocyte/macrophage-derived soluble CD163 was associated with higher stage according to the ISS and with other known prognostic factors in multiple myeloma 40, 41. Here, CD163 is linked to plasma cell myeloma.